Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
423 JPY | -2.08% | 0.00% | -39.74% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Sales 2024 | - | Sales 2025 * | - | Capitalization | 29.03B 188M |
---|---|---|---|---|---|
Net income 2024 | -2.64B -17.1M | Net income 2025 * | -3.3B -21.31M | EV / Sales 2024 | - |
Net cash position 2024 * | 5.65B 36.5M | Net Debt 2025 * | 226M 1.46M | EV / Sales 2025 * | - |
P/E ratio 2024 |
-14
x | P/E ratio 2025 * |
-8.62
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.15% |
Latest transcript on SanBio Company Limited
1 day | -2.08% | ||
Current month | -4.94% | ||
1 month | -42.84% | ||
3 months | -30.08% | ||
6 months | -29.26% | ||
Current year | -39.74% |
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 13-02-28 |
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Toru Kawanishi
CHM | Chairman | 56 | 13-02-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 423 | -2.08% | 583 100 |
24-04-18 | 432 | +1.41% | 458,400 |
24-04-17 | 426 | +3.65% | 883,400 |
24-04-16 | 411 | -1.20% | 460,100 |
24-04-15 | 416 | -1.19% | 289,800 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.74% | 192M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- 4592 Stock